Tuesday, 27 September 2022 01:20 PM
Environmental, Social and Governance
NORTHAMPTON, MA / ACCESSWIRE / September 27, 2022 / 65% of heavy drinkers responded "yes" when asked if they have ever been concerned about their drinking, yet only 26% have sought treatment. It's important to know that treatment and support are available. If you are concerned about your drinking, talk to your healthcare provider. The National Institute on Alcohol Abuse and Alcoholism is a helpful resource to learn more: https://bit.ly/3BhluBf
About Alkermes
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
View additional multimedia and more ESG storytelling from Alkermes on 3blmedia.com.
Contact Info:
Spokesperson: Alkermes
Website: http://www.alkermes.com/
Email: [email protected]
SOURCE: Alkermes